EXAS — Exact Sciences Income Statement
0.000.00%
- $20.03bn
- $21.40bn
- $3.25bn
Annual income statement for Exact Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | C2022 December 31st | C2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,767 | 2,084 | 2,500 | 2,759 | 3,247 |
| Cost of Revenue | |||||
| Gross Profit | 1,308 | 1,423 | 1,762 | 1,919 | 2,263 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 2,623 | 2,678 | 2,704 | 3,797 | 3,453 |
| Operating Profit | -856 | -594 | -205 | -1,038 | -206 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -843 | -633 | -202 | -1,036 | -204 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -596 | -624 | -204 | -1,029 | -208 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -596 | -624 | -204 | -1,029 | -208 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -596 | -624 | -204 | -1,029 | -208 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.08 | -3.48 | -1.17 | -2.55 | -1.08 |